SEC CHARGES NOVARTIS WITH FCPA VIOLATIONS

On 25 June, a release on Mondo Visione advised that the SEC has announced that Novartis AG, a global pharmaceutical and healthcare company headquartered in Switzerland, has agreed to pay over $112 million to settle charges that it violated the books and records and internal accounting controls provisions of the FCPA.  The allegations relate to improper payments or to provide benefits to public and private healthcare providers in South Korea, Vietnam, and Greece in exchange for prescribing or using Novartis or Alcon products.

https://mondovisione.com/media-and-resources/news/sec-charges-novartis-ag-with-fcpa-violations/

https://mondovisione.com/media-and-resources/news/us-department-of-justice-novartis-hellas-saci-and-alcon-pte-ltd-agree-to-pa/

 

 

If you would like to say thanks by making a small contribution, in case I need to upgrade or replace my computers and other paraphernalia, I have a page at https://www.buymeacoffee.com/KoIvM842y

Author: raytodd2017

Chartered Legal Executive and former senior manager with Isle of Man Customs and Excise, where I was (amongst other things) Sanctions Officer (for UN/EU sanctions), Export Licensing Officer and Manager of the Legal-Library & Collectorate Support Section

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s